Skip to main content
Canadian Urological Association Journal logoLink to Canadian Urological Association Journal
. 2017 Aug;11(8):255–259. doi: 10.5489/cuaj.4251

Childhood bladder and bowel dysfunction predicts irritable bowel syndrome phenotype in adult interstitial cystitis/bladder pain syndrome patients

R Christopher Doiron 1, Barry A Kogan 2, Victoria Tolls 1, Karen Irvine-Bird, J Curtis Nickel 1,
PMCID: PMC5542834  PMID: 28798827

Abstract

Introduction

Many clinicians have suggested that a history of bladder and bowel dysfunction (BBD) in childhood predisposes to the development of interstitial cystitis/bladder pain syndrome (IC/BPS) or irritable bowel syndrome (IBS) in adulthood. We hypothesized that BBD symptoms in childhood would predict the IBS-associated phenotype in adult IC/BPS patients.

Methods

Consecutive female patients (n=190) with a diagnosis of IC/BPS were administered a modified form of a clinical BBD questionnaire (BBDQ) to capture childhood BBD-like symptoms, as well as Interstitial Cystitis Symptoms Index (ICSI), Interstitial Cystitis Problem Index (ICPI), Pelvic Pain and Urgency/Frequency (PUF) questionnaires and UPOINT categorization. Patients were stratified to IBS-positive or IBS-negative according to clinical assessment of IBS-like symptoms.

Results

The 127 patients (67%) identified with IBS-like symptoms recalled significantly higher BBDQ scores than the 63 patients (33%) who were IBS-negative (2.8 vs. 2.3; p=0.05). The IBS-positive patients also reported a higher number of UPOINT domains than their non-IBS counterparts (3.8 vs. 2.9; p=0.0001), while their PUF total scores were significantly higher (13.6 vs. 12.3; p=0.04). IBS-positive patients more often recalled that in childhood they did not have a daily bowel movement (BM) (p=0.04) and had “to push for a BM” (p=0.009). In childhood, they “urinated only once or twice per day” (p=0.03) and recalled “painful urination” more than those without IBS (p=0.03). There were no significant differences between the groups in answers to the other five questions of the BBDQ.

Conclusions

Our symptom recollection survey was able to predict the IBS phenotype of IC/BPS based on a childhood BBDQ. Further prospective studies are needed to further evaluate these novel findings.

Introduction

Interstitial cystitis/bladder pain syndrome (IC/BPS) patients represent a heterogeneous group of individuals, often with varied clinical phenotypes.13 Although lacking clear diagnostic criteria, the disease is characterized with pain in the bladder and pelvic floor and is associated with urinary frequency and urgency. The patho-etiology of IC/BPS has remained enigmatic, although several theories have been proposed.410 The demonstration from several clinicians2,1115 of an association between childhood bladder and bowel dysfunction (BBD; previously called dysfunctional elimination syndrome or DES) and the development of lower urinary tract symptoms (LUTS) in adulthood supports a longitudinal process in some patients with overactive bladder (OAB). The strong prevalence of irritable bowel syndrome (IBS) in patients with IC/BPS has been identified by many authors.1620 The complex interplay of neurological, musculoskeletal, and immunological systems allows ample opportunity for early dysfunction of the bladder to be expressed in the adult as symptoms of IC/BPS, and because bowel dysfunction is clearly associated with bladder problems in children, this may well be found, especially in those adults with an IBS phenotype.

This longitudinal theory of progressive pathophysiology to account for some cases of adult IC/BPS has remained challenging to study, as no comprehensive transitional urology program appears to have prospective data to allow for such an analysis. Although fraught with limitations, an opportunity exists to evaluate patient recollections of BBD symptoms in childhood in an IC/BPS population. We explored the childhood history of BBD in female patients with IC/BPS and hypothesized that a history of childhood of BBD would predict the IBS-associated phenotype in female IC/BPS patients.

Methods

Participants and study design

Consecutive female patients with a diagnosis of IC/BPS from a single outpatient clinic who make up a large prospective clinical quality assurance database of IC/BPS patients were administered a modified BBD questionnaire (BBDQ). This patient sample has been described in previous publications.21 Briefly, the patient population consisted of English-speaking female patients who mostly would have met the IC/BPS diagnostic criteria as described in the IC Data Base Study.22

Patients were stratified to IBS-positive or IBS-negative according to clinical assessment of IBS-like symptoms using the Rome III criteria.23 The criteria requires recurrent abdominal pain or discomfort (uncomfortable sensation not described as pain) at least three days per month associated with two or more of: 1) improvement with defecation; 2) onset associated with change in frequency of stool; or 3) onset associated with change in form (appearance) of stool.23,24 The IBS-positive group was further substratified into those with a formal IBS diagnosis vs. those with IBS-like symptoms according to the Rome III criteria, but without a formal diagnosis of IBS. Further substratification among the IBS-positive group included IBS subtypes: IBS-constipation (IBS-C), IBS-diarrhea (IBS-D), and IBS-mixed (IBS-M). This study was done under ongoing institutional review board approval for continued quality assurance with all patient data de-identified before analysis.

Measures

All patients completed the Dysfunctional Voiding Symptom Score (DVSS) questionnaire,25 as well as the BBDQ, which was modified from the DVSS questionnaire to capture childhood BBD-like symptoms. The modified BBDQ addresses the following domains: constipation, urine holding, urinary continence, urinary urgency, obstruction, and dysuria. The modification asked the subject to recall if the symptoms were present in childhood, specifically between the ages of 8 and 10. Data regarding the patients’ demographics, symptom duration, Interstitial Cystitis Symptoms Index (ICSI), Interstitial Cystitis Problem Index (ICPI) scores,26 Pelvic Pain and Urgency/Frequency (PUF), UPOINT scoring,27 and the presence or absence of IBS (diagnosed and/or Rome III criteria) were collected through initial evaluations at the IC/BPS outpatient clinic and has been previously reported.9

Data analysis

Statistical analysis was completed using Microsoft Excel 2010 Data Analysis package and the online Social Science Statistics software (http://www.socscistatistics.com). Age and relevant questionnaire scores (ICSI, UPOINT, ICPI, PUF, BBDQ) were analyzed as quantitative data using a two-tailed t-test assuming unequal variances. Categorical data including IBS subtype, diagnosed or undiagnosed, and DVSS and BBDQ categorical questions were analyzed using a two-tailed z-test for population proportions. All analysis was done used the statistical significance of 0.05.

Results

Of the 190 patients assessed, 127 (67%) were identified as having IBS-like symptoms, while the remaining 63 (33%) did not. The IBS-positive patients did not recall having daily bowel movements (BMs) as children (p=0.04) and remembered having to push during their BMs (p=0.009) as children significantly more than their IBS-negative IC/BPS counterparts. Compared to those without IBS, they also recalled urinating only once or twice daily as children (p=0.03), while their voiding in childhood was considered painful (p=0.03). There were no significant differences in the remaining five questions of the childhood BBDQ (daytime/nighttime wetness, hold urinating by squatting and crossing legs, could not wait to void, and had to push to void). These results are shown in Table 1.

Table 1.

BBDQ results for IBS-yes vs. IBS-no based on Rome III criteria for IC/BPS patients treated at a single outpatient clinic

Between the ages of 8 and 10, average (SD) IBS-yes (n=127) IBS-no (n=63) p
Wet clothes daytime 22 (17.3) 8 (12.1) 0.4
Wet clothes nighttime 27 (21.3) 7 (11.1) 0.08
No daily BM 62 (48.8) 21 (33.3) 0.04
Push during BM 55 (43.3) 15 (23.8) 0.009
Urinate once or twice daily 31 (24.4) 25 (39.7) 0.03
Hold urine by crossing legs or squatting 76 (59.8) 44 (69.8) 0.2
Could not wait to void 36 (28.3) 13 (20.6) 0.3
Had to push to void 21 (16.5) 5 (7.9) 0.1
Painful urination 26 (20.5) 5 (7.9) 0.03

Over the past month, average (SD) IBS-yes (n=127) IBS-no (n=63) p

Wet clothes daytime 64 (50.4) 24 (38.1) 0.1
Wet clothes nighttime 22 (17.3) 5 (7.9) 0.08
No daily BM 71 (55.9) 28 (44.4) 0.1
Push during BM 77 (60.6) 21 (33.3) 0.0004
Urinate once or twice daily 5 (3.9) 1 (1.6) 0.4
Hold urine by crossing legs or squatting 46 (36.2) 23 (36.5) 1.0
Could not wait to void 84 (66.1) 38 (60.3) 0.4
Painful urination 80 (63.0) 32 (50.8) 0.1
Had to push to void 59 (46.5) 15 (23.8) 0.003

BBDQ: bladder and bowel dysfunction questionnaire; BM: bowel movements; IBS: irritable bowel syndrome; IC/BPS: interstitial cystitis/bladder pain syndrome; SD: standard deviation.

The IBS-positive patients’ pushing during BMs and voiding persisted in adulthood significantly more than those with no IBS-like symptoms (p=0.0004 and 0.003, respectively; Table 1). The IC/BPS patients with IBS-like symptoms did have significantly more UPOINT domains reported (3.8 vs. 2.9; p=0.0001). Their total childhood BBDQ scores were also significantly higher than IC/BPS patients without IBS (2.8 vs. 2.3; p=0.05). Furthermore, their PUF symptom score was significantly increased (13.6 vs. 12.3; p=0.04); however, their ICSI, ICPI, and total PUF scores, although numerically increased, were not significantly different (Table 2).

Table 2.

BBDQ scores, UPOINT categorizations, ICSI, ICPI, and PUF scores for IBS-yes vs. IBS-no based on Rome III criteria for IC/BPS patients treated at a single outpatient clinic

n Age BBD child total UPOINT total ICSI total ICPI total Sx score total PUF Bother score total PUF PUF total
IBS-yes 127 45.8 (16.8) 2.8 (1.9) 3.8 (1.4) 13.7 (4.3) 11.6 (3.7) 13.6 (4.8) 7.0 (2.9) 20.6 (7.4)
IBS-no 63 48.9 (18.7) 2.3 (1.6) 2.9 (1.3) 12.9 (3.9) 11.1 (3.4) 12.3 (3.6) 6.7 (2.5) 18.9 (5.5)
p 0.3 0.05 0.0001 0.2 0.4 0.04 0.4 0.09

BBDQ: bladder and bowel dysfunction questionnaire; IBS: irritable bowel syndrome; IC/BPS: interstitial cystitis/bladder pain syndrome; ICPI: Interstitial Cystitis Problem Index; ICSI: Interstitial Cystitis Symptom Index; PUF: Pelvic Pain and Urgency/Frequency Patient Symptom Scale.

A stratified analysis looking at those diagnosed with IBS vs. those found to have IBS-like symptoms according to Rome III criteria, but without a formal IBS diagnosis, did not show any significant differences in the BBDQ (data not shown). A further stratified analysis compared subtypes of IBS, including IBS-C, IBS-D, and IBS-M (Table 3). The constipated subtype pushes significantly more during BMs as adults than both the diarrhea subtype and mixed subtype (p=0.0001 and 0.02, respectively) while the IBS-M subtype pushes significantly more than the IBS-D group (p=0.004). The IBS-C group also noted significantly more “wet clothes” as an adult than the diarrhea group (p=0.001), while the IBS-M subtype was also significantly wetter than the diarrhea group (p=0.03). The only significant differences noted in their childhood symptoms were that the IBS-C group pushed more during BMs than the IBS-M group (p=0.04), but not statistically significantly more than the IBS-D group (p=0.09). The constipated subtype also noted a higher incidence of only urinating once or twice daily than the mixed subtype (p=0.04).

Table 3.

BBDQ results stratified by IBS-subtype; IBS-mixed (IBS-M), IBS-constipation (IBS-C), and IBS-diarrhea (IBS-D)

IBS types IBS-M IBS-C IBS-D IBS-M vs. IBS-C IBS-M vs. IBS-D IBS-C vs. IBS-D
 n 32 43 33 p p p
Between the ages of 8 and 10, average (SD)
 Wet clothes daytime 4 (12.5) 8 (18.6) 7 (21.2) 0.5 0.3 0.9
 Wet clothes nighttime 8 (25.0) 7 (16.3) 8 (24.2) 0.4 0.9 0.4
 No daily BM 15 (46.9) 25 (58.1) 13 (39.4) 0.4 0.5 0.1
 Push during BM 10 (31.3) 24 (55.8) 12 (36.4) 0.03 0.7 0.09
 Urinate once or twice daily 4 (12.5) 14 (32.6) 6 (18.2) 0.04 0.5 0.2
 Hold urine by crossing legs or squatting 21 (65.6) 25 (58.1) 18 (54.5) 0.5 0.4 0.8
 Could not wait to void 13 (40.6) 13 (30.2) 8 (24.2) 0.3 0.2 0.6
 Had to push to void 7 (21.9) 6 (14.0) 5 (15.2) 0.4 0.5 0.9
 Painful urination 9 (28.1) 8 (18.6) 8 (24.2) 0.3 0.7 0.6
Over the past month, average (SD)
 Wet clothes daytime 18(56.3) 29 (67.4) 10 (30.3) 0.3 0.03 0.001
 Wet clothes nighttime 5 (15.6) 7 (16.3) 6 (18.2) 0.9 0.9 0.8
 No daily BM 20 (62.5) 27 (62.8) 13 (39.4) 1.0 0.06 0.04
 Push during BM 20 (62.5) 37 (86.0) 9 (27.3) 0.02 0.004 0.0
 Urinate once or twice daily 2 (6.3) 3 (7.0) 0 (0.0) 0.9 0.1 0.1
 Hold urine by crossing legs or squatting 11 (34.4) 18 (41.9) 13 (39.4) 0.5 0.7 0.8
 Could not wait to void 21 (65.6) 29 (67.4) 24 (72.7) 0.9 0.5 0.6
 Had to push to void 23 (71.9) 30 (69.8) 21 (63.6) 0.8 0.5 0.6
 Painful urination 13 (40.6) 20 (46.5) 16 (48.5) 0.6 0.5 0.9

BBDQ: bladder and bowel dysfunction questionnaire; BM: bowel movements; IBS: irritable bowel syndrome; IC/BPS: interstitial cystitis/bladder pain syndrome; SD: standard deviation.

Discussion

We report childhood BBD symptoms in a cohort of female IC/BPS patients evaluated at a single outpatient clinic. IC/BPS patients with IBS-like symptoms report significantly more BBD symptoms (significantly higher total modified childhood BBDQ scores) and more adult UPOINT domains than their counterparts without IBS-like symptoms. During childhood, those with adult IBS reported significant differences than those without IBS in that they did not have daily BMs, had to push during BMs, voided only once or twice daily, and had painful urination. Although their PUF symptom score was found to be statistically significantly increased as well, this does not likely represent a clinically significant difference.

Several previous studies have reported an association between childhood BBD and adult voiding symptoms. Fitzgerald et al13 administered self-reported questionnaires to a population-based cohort of healthy women and found that several childhood urinary symptoms were predictive of OAB symptoms in adult women. Moore et al15 reported that in 1000 consecutive patients undergoing urodynamic studies, one-third of women and two-thirds of men found to have idiopathic detrusor instability had a history of troublesome enuresis in childhood. Bower et al14 reported that 191 consecutive patients presenting to their urogynecology clinic had higher childhood BBDQ scores than 252 normal women.

These studies, although suggestive of a longitudinal process of bladder and pelvic floor dysfunction, are not directly applicable to the IC/BPS population, as the patients studied were at times undifferentiated and lacked clear diagnoses. Peters et al11 found significantly increased rates of recurrent urinary tract infections (UTIs) and antibiotic usage in childhood of a cohort of IC/BPS patients (n=215) compared to a healthy control population. Furthermore, their IC/BPS patients reported significantly higher rates of urinary urgency, trouble initiating stream, constipation, and painful defecation during childhood compared with the control group.

Our current study is the first of its kind to stratify IC/BPS patients into those with IBS-like symptoms and those without when inquiring about childhood symptoms of BBD. We had hypothesized that the IBS-associated phenotype of IC/BPS patients would more strongly exhibit childhood BBD symptoms and our findings indeed support this. Furthermore, our substratification of IBS-positive patients suggest that the IBS-C group may represent patients who suffered more significantly in childhood. It is furthermore interesting to note that the IBS-C group had numerically higher rates of incontinence in adulthood compared to both the IBS-D and IBS-M groups — albeit the difference was only statistically significant compared to the IBS-D group. This finding may further support that worse childhood symptoms, particularly pushing during BMs and infrequent urination, may manifest in more significant voiding dysfunction in adulthood.

The limitations of this current study are obvious. The exercise of recalling childhood symptoms in a group of IC/BPS patients is undoubtedly wrought with bias. It is however, the only childhood data we have in this population, as no prospective studies of pediatric patients with BBD exist in the literature. In an attempt to mitigate this recall bias, we did specify in the questionnaire for patients to recall symptoms specifically between the ages of 8 and 10. We felt this was an age that would allow for reasonable recollection, but at which the prevalence of BBD would still be high enough to include those who might have suffered.

Furthermore, our current dataset lacks any information about the state of the patients’ disease at the time of questionnaire administration, which could further bias their recollection and was not controlled for. The questionnaire used, although not validated, was modified from a validated questionnaire25 used in the pediatric population. No questionnaires have been fully validated to recall childhood symptoms of BBD and as a result, the best data we can come up with is our patients recalling symptoms as children. Our study is further limited by a lack of control population.

This study provides further insight into a longitudinal theory of BBD and provides new insight into the IBS-associated phenotype of IC/BPS patients. It again highlights a glaring lack of literature studying the longitudinal progression theory of adult IC/BPS developing from symptomatic children. As comprehensive transitional pediatric to adult urology programs develop, one objective should be a prospective database that will answer these type of questions.

Conclusion

IBS-positive IC/BPS patients report higher total BBDQ scores as children and more reported UPOINT domains as adults than IC/BPS patients without IBS. The IBS-C subtype recall suffering worse in childhood and manifest more significant symptoms in adulthood. Prospective studies in pediatric patients with elimination disorders are sorely needed to confirm the longitudinal theory of IC/BPS progression.

Footnotes

Competing interests: Dr. Nickel has been a consultant for Astellas, Auxillium, Eli Lilly, Farr Labs, Ferring, GSK, Pfizer, Taris Biomedical, Tribute, and Trillium Therapeutics; a speaker for Astellas and Eli Lilly; and has participated in clinical trials supported by GSK, Johnson & Johnson, Pfizer, and Taris Biomedical. The remaining authors report no competing personal or financial interests.

This paper has been peer-reviewed.

References


Articles from Canadian Urological Association Journal are provided here courtesy of Canadian Urological Association

RESOURCES